On March 5, 2024, Orgenesis Inc. closed the transaction. The company received $2,340,903 in funding pursuant to exemption provided under Regulation D. The transaction included participation from 46 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 USD | +36.13% |
|
+5.21% | +21.83% |
May. 20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+21.83% | 28.8M | |
-3.95% | 184B | |
-0.90% | 109B | |
-2.27% | 68.87B | |
+15.24% | 46.61B | |
-6.00% | 46.39B | |
+5.36% | 40.74B | |
+20.65% | 31.26B | |
+11.60% | 24B | |
-5.50% | 24.24B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it has received $2.340901 million in funding